ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

MGTX vs PRME // EV/EBITDA & P/E VALUATION

MeiraGTx Holdings plc (NASDAQ) VS. Prime Medicine Inc. (NASDAQ) • 15-METRIC TALLY: MGTX 2 — PRME 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MGTX VS. PRME) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC MGTX PRME SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield -5.38% -17.58% +12.20 MGTX /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) 144.60% 55.30% +89.30 MGTX /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 0.20 0.00 TIE /balance-sheet <GO>
Piotroski F-Score Quality 1/9 3/9 -2.00 PRME /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 38.3 61.5 -23.21 PRME /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $932.1M $950.4M -$18.3M PRME /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR MGTX REV PRME REV MGTX GROSS % PRME GROSS % MGTX FCF PRME FCF
FY 2025 $81.4M $4.6M — — -$50.2M -$167.1M
FY 2024 $33.3M $3.0M — — -$109.5M -$130.2M
FY 2023 $14.0M $0 — — -$105.4M -$165.4M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MGTX // BETA —
PRME // BETA —